Association of the glycemic background patterns and the diabetes management efficacy in poorly controlled type 2 diabetes

Table 3 Clinical outcomes after 12 months for group a and group B, mean ± SD, n (%)

	Group A (1 + 2) (n = 51)	Group B (2 + 3) (n = 81)	All patients (n = 132)	P value
Weight (kg)	84 ± 14	80 ± 14	82 ± 14	0.159
BMI (kg/m2)	30 ± 4.5	30.4 ± 5.2	30.2 ± 4.9	0.942
Waist circumference (cm)	102.5 ± 12.4	102.7 ± 14	102 (16)	0.741
Glucose (mg/dL)	133.5 (36.8)	172.9 ± 57.5	145 (77)	0.000a
LDL-C (mg/dL)	86.1 ± 33.6	95.7 ± 36.8	91.9 ± 35.7	0.335
HDL-C (mg/dL)	46.1 ± 15.1	45 ± 9.5	45.4 ± 11.9	0.390
Triglyceride (mg/dL)	153 (123.8)	155 ± 87	155 (100)	0.566
Total cholesterol (mg/dL)	166.9 ± 39.7	173.2 ± 42.9	170.7 ± 41.5	0.382
C-peptide (ng/mL)	2.7 (2)	2.1 (1.9)	2.3 (1.8)	0.012a
HbA1c (%)	7 (1.2)	8.5 (2)	7.8 (2.1)	0.000a

^aP < 0.05.

BMI: Body mass index; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; HbA1c: Glycated hemoglobin.